OPRX / OptimizeRx Corp. (OPRX) Reports Q1 Loss, Tops Revenue Estimates

OptimizeRx Corp. (OPRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions more_horizontal

OptimizeRx Corporation. (NASDAQ:OPRX ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants William Febbo - Chief Executiv more_horizontal

ROCHESTER, Mich., July 31, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technolo more_horizontal

OptimizeRx Corporation provides communication technologies between pharma firms, healthcare providers, and patients. The company has seen material ope more_horizontal

OptimizeRx Corporation (NASDAQ:OPRX ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Will Febbo - Chief Executive Offic more_horizontal

OptimizeRx Corp. (OPRX) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to los more_horizontal

OptimizeRx Corporation is an interesting company with an investment thesis based on its ability to capture a large TAM, with customers being some of t more_horizontal

OptimizeRx Corp. (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not more_horizontal